MLL Rearranged
KMT2A (MLL) rearrangements in acute leukemias. Targeted by emerging menin inhibitors (revumenib, ziftomenib).
No Treatments found for this biomarker.
KMT2A (MLL) rearrangements in acute leukemias. Targeted by emerging menin inhibitors (revumenib, ziftomenib).
No Treatments found for this biomarker.